U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07257627) titled 'Comparative PK/PD of Single-Dose THDB0206 at Different Injection Sites' on Nov. 14.
Brief Summary: This open-label, randomized, three-period crossover, 8-hour hyperinsulinemic-euglycemic clamp study will compare the pharmacokinetic and pharmacodynamic profiles of THDB0206 after single subcutaneous administration at different injection sites in healthy Chinese adults.
Study Start Date: April 17, 2024
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: THDB0206 injection-Upper arm
Subjects received a single subcutaneous injection of THDB0206 at a dose of 0.2 U/kg in the upper arm.
DRUG: THDB0206 Injec...